Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Condition:   Locally Advanced Cervical Cancer Interventions:   Drug: Pembrolizumab;   Drug: Carboplatin;   Drug: Taxol Sponsors:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials